Compile Data Set for Download or QSAR
maximum 50k data
Found 5 Enz. Inhib. hit(s) with Target = 'Cannabinoid receptor 2' and Ligand = 'BDBM242460'
TargetCannabinoid receptor 2(Homo sapiens (Human))
Pharmos

US Patent
LigandPNGBDBM242460(US9422235, 36)
Affinity DataKi:  53nM ΔG°:  -42.2kJ/mole IC50:  106nMT: 2°CAssay Description:The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Pharmos

US Patent
LigandPNGBDBM242460(US9422235, 36)
Affinity DataKi:  66nM ΔG°:  -41.7kJ/mole IC50:  132nMT: 2°CAssay Description:The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Pharmos

US Patent
LigandPNGBDBM242460(US9422235, 36)
Affinity DataKi:  68nM ΔG°:  -41.6kJ/mole IC50:  132nMT: 2°CAssay Description:The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Pharmos

US Patent
LigandPNGBDBM242460(US9422235, 36)
Affinity DataKi:  131nM ΔG°:  -39.9kJ/mole IC50:  215nMT: 2°CAssay Description:The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Pharmos

US Patent
LigandPNGBDBM242460(US9422235, 36)
Affinity DataKi:  822nM ΔG°:  -35.3kJ/mole IC50:  1.93E+3nMT: 2°CAssay Description:The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent